SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy symbol is currently trending as speculative investors debate whether this Solana-based project will replicate the extreme volatility and parabolic runs of previous cycles. While proponents urge community-led accumulation and hype to trigger a comeback, vocal critics warn of potential rug pulls and label the asset a recurring scam modeled after past market failures.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors remain polarized, with some anticipating significant price appreciation fueled by the potential passage of the Clarity Act and institutional adoption, while others condemn the project as a long-term failure and a scam. Community discourse is dominated by intense debates between 'bag holders' hoping for a breakthrough in payment infrastructure and vocal bears who point to years of consistent decline as evidence that the token has no future.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for community discussion as investors debate its long-term potential versus recent price volatility, with many highlighting its post-quantum security features and institutional moves as catalysts for future growth. While some traders are actively monitoring entry points for accumulation, others are expressing frustration over the project's extended drawdown and shifts in the broader digital asset landscape.

Maul Coin

Maul Coin is trending as the community rallies around rapid holder growth and grassroots promotion, actively pushing for exchange visibility despite the lack of an official chart. Investors are debating the project's long-term potential as a meme-driven movement, highlighting the developer's transparency and ongoing community efforts as primary catalysts for current momentum.

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Pulse Biosciences Inc

Pulse Biosciences is capturing investor attention as the company advances its proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology, with the community actively monitoring positive clinical trial data and potential breakthrough developments in cardiac and soft tissue treatment. Investors are closely tracking strategic insider activity and long-term clinical trial milestones, frequently discussing the potential for a transformative breakthrough in the atrial fibrillation market.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid a mixture of intense frustration over long-term price stagnation and renewed optimism surrounding upcoming regulatory clarity and potential institutional integration. While some investors are exiting positions due to boredom and lack of momentum, others are actively accumulating tokens in anticipation of utility-driven demand and legislative breakthroughs.

COTI is a fast and light confidentiality layer on Ethereum. Powered by the breakthrough cryptographic protocol Garbled Circuits and secured by Ethereum, COTI introduces the most advanced and compliant solution for data protection on the public blockchain. Paving the way for the next wave of Web3 innovation and adoption, COTI unlocks a whole new world of use cases, including confidential transactions, Artificial Intelligence, DeFi, decentralized identification, and more.

COTI

COTI is gaining significant momentum and attention as the community rallies around its innovative garbled circuits technology and the recent transition to mainnet. Investors are actively discussing the protocol's potential to provide programmable, compliant privacy for real-world assets, with many highlighting its perceived competitive edge and growth potential in the evolving privacy sector.

Vanguard International Equity Index Funds - Vanguard FTSE Europe ETF

Vanguard FTSE Europe ETF

Vanguard FTSE Europe ETF (VGK) is facing heightened volatility as investors grapple with shifting geopolitical tensions, energy inflation fears, and the European Central Bank's potential path toward forced hawkishness. While some community members are using the fund for long-term geographic diversification to mitigate U.S. concentration risk, others are expressing concern over the economic impact of regional instability and are debating whether to hedge or reduce exposure during this period of uncertainty.

iShares Trust - iShares Russell 2000 Value ETF

iShares Russell 2000 Value ETF

The iShares Russell 2000 Value ETF ($IWN) is trending as investors debate the impact of potential new tariffs on steel and aluminum imports, leading to increased focus on how these policy shifts will influence small-cap valuations and supply chain costs. Community discussions are currently dominated by concerns over whether these trade measures will spark a domestic economic slowdown or if the small-cap sector offers a resilient rotation opportunity amid ongoing market volatility.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XinFin Network (XDC) is generating buzz as traders speculate on potential institutional adoption, driven by the broader narrative of ISO 20022 compliance and its role in trade finance. Community sentiment remains deeply divided between long-term holders anticipating a 'sleeping giant' breakout and impatient traders frustrated by stagnant price action and low volume compared to other utility assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioNexus Gene Lab Corp. (BGLC) announced on Wednesday that it has entered into definitive agreements with Asia-based firms Fidelion Diagnostics Pte. and Tongshu Biotechnology, among other parties, to commercialize VitaGuard in Southeast Asia.VitaGuard is a high-fidelity, tumor-naïve liquid biopsy platform for minimal residual disease, meaning it detects tiny fragments of tumor DNA without requiring a tumor tissue sample. Minimal residual disease (MRD) is a small number of cancer cells that remain in the body during or after treatment, which are undetectable by standard methods.<h2 class="st-heading-2">Transaction Terms And Details</h2>China-headquartered Tongshu Gene is the original developer of the VitaGuard technology. The firm serves as the research and development, as well as manufacturing partner of Singapore-based Fidelion.The partnership <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/12/3186213/0/en/BioNexus-Gene-Lab-Corp-Nasdaq-BGLC-Announces-Strategic-Agreements-with-Fidelion-Diagnostics-for-Southeast-Asia-MRD-Commercialization.html">aims</a> to support the planned commercialization of MRD testing in Southeast Asia with an initial focus in Singapore and Malaysia.Under the agreement, BGLC will receive new Fidelion shares equal to at least 15 % of Fidelion’s fully diluted share capital, and Fidelion will receive newly issued, restricted BGLC shares equal to 19.9% of BGLC’s pre-money outstanding shares. The BGLC share issuance will be made in a private transaction, the company said.The completion of the transaction is conditioned upon an Intellectual Property License Agreement granting BGLC exclusive commercialization rights across the Association of Southeast Asian Nations.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/BGLC">BGLC stock</a> jumped from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘extremely low’ to ‘extremely high’ levels.BGLC stock is up 68% this year and approximately 42% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/toyota-commits-up-to-10-billion-additional-investment-in-us-over-five-years/cLPI6vHREdJ">Toyota Commits Up To $10B Additional Investments In US Over Five Years</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Esperion’s stock (ESPR) has risen 40.5% so far in 2025. (Representative Image: Getty Images)

BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention?

The partnership aims to support the planned commercialization of minimal residual disease testing in Southeast Asia.

Equity

The partnership aims to support the planned commercialization of minimal residual disease testing in Southeast Asia.


BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

BGLC
BioNexus Gene Lab Corp

Feed

News

Sentiment

Fundamentals

Info

Latest BGLC News

BGLCBioNexus Gene Lab Corp